Cargando…

Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery

The present study was aimed at evaluating the possible use of inter polymer complexed (IPC) films of chitosan (CH) and carboxymethyl tamarind kernel powder (CMTKP) for colon release of budesonide. Viscosity analysis of the supernatant liquid obtained after reacting CH and CMTKP in different proporti...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Gurpreet, Jain, Subheet, Tiwary, Ashok K.
Formato: Texto
Lenguaje:English
Publicado: Österreichische Apotheker-Verlagsgesellschaft 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002829/
https://www.ncbi.nlm.nih.gov/pubmed/21179370
http://dx.doi.org/10.3797/scipharm.0908-10
_version_ 1782193793051656192
author Kaur, Gurpreet
Jain, Subheet
Tiwary, Ashok K.
author_facet Kaur, Gurpreet
Jain, Subheet
Tiwary, Ashok K.
author_sort Kaur, Gurpreet
collection PubMed
description The present study was aimed at evaluating the possible use of inter polymer complexed (IPC) films of chitosan (CH) and carboxymethyl tamarind kernel powder (CMTKP) for colon release of budesonide. Viscosity analysis of the supernatant liquid obtained after reacting CH and CMTKP in different proportions revealed 40:60 to be the optimum stoichiometric ratio. The FTIR spectra of IPC films formed from 50:50 or 40:60 ratio of CH:CMTKP did not reveal any reduction in the peaks at 1560cm(−1) and 1407cm(−1) after exposure to pH 1.2, suggesting resistance of the interaction between −COO(−) groups of CMTKP and −NH(3)(+) groups of CH to gastric pH. Tablets containing Avicel pH 102 as diluent and coated to a weight gain of 10%, w/w with aqueous solutions of 40:60 or 50:50 ratio of CH:CMTKP did not release budesonide in pH 1.2 buffer. Histopathology of the rat colon after oral administration of these IPC film coated tablets revealed significantly greater (p<0.05) reduction in TNBS-induced ulcerative colitis as compared to that after administration of uncoated tablets. The Cmax of budesonide achieved after oral administration of these IPC film coated tablets was comparable to that observed after administration of uncoated tablets. The results strongly indicate versatility of CH-CMTKP IPC films to deliver budesonide in the colon.
format Text
id pubmed-3002829
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Österreichische Apotheker-Verlagsgesellschaft
record_format MEDLINE/PubMed
spelling pubmed-30028292010-12-22 Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery Kaur, Gurpreet Jain, Subheet Tiwary, Ashok K. Sci Pharm Original Papers The present study was aimed at evaluating the possible use of inter polymer complexed (IPC) films of chitosan (CH) and carboxymethyl tamarind kernel powder (CMTKP) for colon release of budesonide. Viscosity analysis of the supernatant liquid obtained after reacting CH and CMTKP in different proportions revealed 40:60 to be the optimum stoichiometric ratio. The FTIR spectra of IPC films formed from 50:50 or 40:60 ratio of CH:CMTKP did not reveal any reduction in the peaks at 1560cm(−1) and 1407cm(−1) after exposure to pH 1.2, suggesting resistance of the interaction between −COO(−) groups of CMTKP and −NH(3)(+) groups of CH to gastric pH. Tablets containing Avicel pH 102 as diluent and coated to a weight gain of 10%, w/w with aqueous solutions of 40:60 or 50:50 ratio of CH:CMTKP did not release budesonide in pH 1.2 buffer. Histopathology of the rat colon after oral administration of these IPC film coated tablets revealed significantly greater (p<0.05) reduction in TNBS-induced ulcerative colitis as compared to that after administration of uncoated tablets. The Cmax of budesonide achieved after oral administration of these IPC film coated tablets was comparable to that observed after administration of uncoated tablets. The results strongly indicate versatility of CH-CMTKP IPC films to deliver budesonide in the colon. Österreichische Apotheker-Verlagsgesellschaft 2010 2009-12-03 /pmc/articles/PMC3002829/ /pubmed/21179370 http://dx.doi.org/10.3797/scipharm.0908-10 Text en © Kaur et al.; licensee Österreichische Apotheker-Verlagsgesellschaft m. b. H., Vienna, Austria. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Papers
Kaur, Gurpreet
Jain, Subheet
Tiwary, Ashok K.
Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery
title Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery
title_full Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery
title_fullStr Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery
title_full_unstemmed Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery
title_short Chitosan-Carboxymethyl Tamarind Kernel Powder Interpolymer Complexation: Investigations for Colon Drug Delivery
title_sort chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery
topic Original Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002829/
https://www.ncbi.nlm.nih.gov/pubmed/21179370
http://dx.doi.org/10.3797/scipharm.0908-10
work_keys_str_mv AT kaurgurpreet chitosancarboxymethyltamarindkernelpowderinterpolymercomplexationinvestigationsforcolondrugdelivery
AT jainsubheet chitosancarboxymethyltamarindkernelpowderinterpolymercomplexationinvestigationsforcolondrugdelivery
AT tiwaryashokk chitosancarboxymethyltamarindkernelpowderinterpolymercomplexationinvestigationsforcolondrugdelivery